Raymond James & Associates »

Halozyme Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $16M 274k 57.24
2024-06-30 $7.7M 146k 52.36
2024-03-31 $3.9M 96k 40.68
2023-12-31 $2.6M 71k 36.96
2023-09-30 $3.0M 77k 38.20
2023-06-30 $2.8M 78k 36.07
2023-03-31 $4.1M 107k 38.19
2022-12-31 $5.9M 104k 56.90
2022-09-30 $3.0M 75k 39.54
2022-06-30 $1.8M 42k 44.00
2022-03-31 $1.3M 33k 39.88
2021-12-31 $2.1M 51k 40.22
2021-09-30 $1.4M 35k 40.69
2021-06-30 $1.6M 36k 45.41
2021-03-31 $1.3M 30k 41.67
2020-12-31 $2.1M 48k 42.70
2020-09-30 $803k 31k 26.27
2020-06-30 $607k 23k 26.81
2020-03-31 $396k 22k 18.00
2019-12-31 $422k 24k 17.72
2019-09-30 $368k 24k 15.51
2018-09-30 $272k 15k 18.15
2018-06-30 $222k 13k 16.88
2017-12-31 $216k 11k 20.22
2016-09-30 $142k 12k 12.06
2016-06-30 $101k 12k 8.65
2016-03-31 $113k 12k 9.44
2015-12-31 $207k 12k 17.29
2015-09-30 $223k 17k 13.46
2015-06-30 $366k 16k 22.59
2015-03-31 $432k 30k 14.28
2014-12-31 $264k 27k 9.64
2014-09-30 $216k 24k 9.11
2014-06-30 $219k 22k 9.86
2014-03-31 $208k 16k 12.68
2013-12-31 $240k 16k 15.00